Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BPMC

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BPMC
DateTimeSourceHeadlineSymbolCompany
06/03/20239:00AMPR Newswire (US)Blueprint Medicines Highlights Clinical Progress Across Precision Oncology Pipeline at 2023 ASCO Annual MeetingNASDAQ:BPMCBlueprint Medicines Corporation
05/23/202310:00AMPR Newswire (US)NEJM Evidence Publishes Results from Registrational PIONEER Trial Demonstrating Significant Clinical Benefits of AYVAKIT® (avapritinib) in Patients with Indolent Systemic MastocytosisNASDAQ:BPMCBlueprint Medicines Corporation
05/22/20235:27PMDow Jones NewsBlueprint Medicines Gets FDA Approval for AyvakitNASDAQ:BPMCBlueprint Medicines Corporation
05/22/20234:54PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
05/22/20234:04PMPR Newswire (US)FDA Approves AYVAKIT® (avapritinib) as the First and Only Treatment for Indolent Systemic MastocytosisNASDAQ:BPMCBlueprint Medicines Corporation
05/10/20235:02PMEdgar (US Regulatory)Ammended Annual Report to Security Holders (ars/a)NASDAQ:BPMCBlueprint Medicines Corporation
05/04/20235:01PMPR Newswire (US)Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BPMCBlueprint Medicines Corporation
05/04/20237:19AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
05/04/20237:00AMPR Newswire (US)Blueprint Medicines Reports First Quarter 2023 ResultsNASDAQ:BPMCBlueprint Medicines Corporation
05/01/20236:04AMEdgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:BPMCBlueprint Medicines Corporation
04/28/20235:35PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BPMCBlueprint Medicines Corporation
04/26/202310:00AMPR Newswire (US)Blueprint Medicines to Present New Clinical Data Across Broad Precision Therapy Pipeline at 2023 ASCO Annual MeetingNASDAQ:BPMCBlueprint Medicines Corporation
04/20/20234:01PMPR Newswire (US)Blueprint Medicines to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023NASDAQ:BPMCBlueprint Medicines Corporation
04/11/20238:00AMPR Newswire (US)Blueprint Medicines to Present at Upcoming Investor ConferencesNASDAQ:BPMCBlueprint Medicines Corporation
04/05/20234:01PMPR Newswire (US)Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BPMCBlueprint Medicines Corporation
03/28/20235:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
03/28/20234:05PMPR Newswire (US)Blueprint Medicines Announces Lift of Partial Clinical Hold on Phase 1/2 VELA Trial of BLU-222NASDAQ:BPMCBlueprint Medicines Corporation
03/07/20234:01PMPR Newswire (US)Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BPMCBlueprint Medicines Corporation
02/26/20233:00PMPR Newswire (US)Blueprint Medicines Presents Registrational Data from PIONEER Trial of AYVAKIT® (avapritinib) in Patients with Indolent Systemic Mastocytosis at 2023 AAAAI Annual MeetingNASDAQ:BPMCBlueprint Medicines Corporation
02/23/20234:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
02/23/20238:00AMPR Newswire (US)Blueprint Medicines to Regain Global Rights to GAVRETO® (pralsetinib) from RocheNASDAQ:BPMCBlueprint Medicines Corporation
02/17/20238:13AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BPMCBlueprint Medicines Corporation
02/17/20238:08AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BPMCBlueprint Medicines Corporation
02/17/20237:38AMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:BPMCBlueprint Medicines Corporation
02/16/20235:26PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:BPMCBlueprint Medicines Corporation
02/16/20238:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
02/16/20237:00AMPR Newswire (US)Blueprint Medicines Reports Fourth Quarter and Full Year 2022 ResultsNASDAQ:BPMCBlueprint Medicines Corporation
02/14/202312:41PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BPMCBlueprint Medicines Corporation
02/10/20238:49AMDow Jones NewsBlueprint Medicines BLU-222 Study on FDA Partial HoldNASDAQ:BPMCBlueprint Medicines Corporation
02/10/20238:27AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
 Showing the most relevant articles for your search:NASDAQ:BPMC